210 related articles for article (PubMed ID: 31831742)
1. Integrated exome and RNA sequencing of dedifferentiated liposarcoma.
Hirata M; Asano N; Katayama K; Yoshida A; Tsuda Y; Sekimizu M; Mitani S; Kobayashi E; Komiyama M; Fujimoto H; Goto T; Iwamoto Y; Naka N; Iwata S; Nishida Y; Hiruma T; Hiraga H; Kawano H; Motoi T; Oda Y; Matsubara D; Fujita M; Shibata T; Nakagawa H; Nakayama R; Kondo T; Imoto S; Miyano S; Kawai A; Yamaguchi R; Ichikawa H; Matsuda K
Nat Commun; 2019 Dec; 10(1):5683. PubMed ID: 31831742
[TBL] [Abstract][Full Text] [Related]
2. Integrated genomic and transcriptomic analysis revealed mutation patterns of de-differentiated liposarcoma and leiomyosarcoma.
Liu W; Tong H; Zhang C; Zhuang R; Guo H; Lv C; Yang H; Lin Q; Guo X; Wang Z; Wang Y; Shen F; Wang S; Dai C; Wang G; Liu J; Lu W; Zhang Y; Zhou Y
BMC Cancer; 2020 Oct; 20(1):1035. PubMed ID: 33115433
[TBL] [Abstract][Full Text] [Related]
3. Pathogenic NF1 truncating mutation and copy number alterations in a dedifferentiated liposarcoma with multiple lung metastasis: a case report.
Kim YS; Shin S; Jung SH; Chung YJ
BMC Med Genet; 2020 Oct; 21(1):200. PubMed ID: 33046013
[TBL] [Abstract][Full Text] [Related]
4. Genomic Evolutionary Patterns of Leiomyosarcoma and Liposarcoma.
Amin-Mansour A; George S; Sioletic S; Carter SL; Rosenberg M; Taylor-Weiner A; Stewart C; Chevalier A; Seepo S; Tracy A; Getz G; Hornick JL; Nucci MR; Quade B; Demetri GD; Raut CP; Garraway LA; Van Allen EM; Wagner AJ
Clin Cancer Res; 2019 Aug; 25(16):5135-5142. PubMed ID: 31164371
[TBL] [Abstract][Full Text] [Related]
5. Update on genomic and molecular landscapes of well-differentiated liposarcoma and dedifferentiated liposarcoma.
Lu J; Wood D; Ingley E; Koks S; Wong D
Mol Biol Rep; 2021 Apr; 48(4):3637-3647. PubMed ID: 33893924
[TBL] [Abstract][Full Text] [Related]
6. Whole exome sequencing of well-differentiated liposarcoma and dedifferentiated liposarcoma in older woman: a case report.
Zhao Z; Chen X; Xu J; Shi Y; Mak TK; Huo M; Zhang C
Front Med (Lausanne); 2023; 10():1237246. PubMed ID: 37649981
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the 12q amplicons in lipomatous soft tissue tumors by multiplex ligation-dependent probe amplification-based copy number analysis.
Creytens D; Van Gorp J; Speel EJ; Ferdinande L
Anticancer Res; 2015 Apr; 35(4):1835-42. PubMed ID: 25862836
[TBL] [Abstract][Full Text] [Related]
8. Genomic profiling of dedifferentiated liposarcoma compared to matched well-differentiated liposarcoma reveals higher genomic complexity and a common origin.
Beird HC; Wu CC; Ingram DR; Wang WL; Alimohamed A; Gumbs C; Little L; Song X; Feig BW; Roland CL; Zhang J; Benjamin RS; Hwu P; Lazar AJ; Futreal PA; Somaiah N
Cold Spring Harb Mol Case Stud; 2018 Apr; 4(2):. PubMed ID: 29610390
[TBL] [Abstract][Full Text] [Related]
9. Genomic alterations and clinical outcomes in patients with dedifferentiated liposarcoma.
Jagosky MH; Anderson CJ; Symanowski JT; Steuerwald NM; Farhangfar CJ; Baldrige EA; Benbow JH; Livingston MB; Patt JC; Ahrens WA; Kneisl JS; Kim ES
Cancer Med; 2023 Mar; 12(6):7029-7038. PubMed ID: 36464833
[TBL] [Abstract][Full Text] [Related]
10. Are peripheral purely undifferentiated pleomorphic sarcomas with MDM2 amplification dedifferentiated liposarcomas?
Le Guellec S; Chibon F; Ouali M; Perot G; Decouvelaere AV; Robin YM; Larousserie F; Terrier P; Coindre JM; Neuville A
Am J Surg Pathol; 2014 Mar; 38(3):293-304. PubMed ID: 24525499
[TBL] [Abstract][Full Text] [Related]
11. Correlation of histological grade of dedifferentiation with clinical outcome in 55 patients with dedifferentiated liposarcomas.
Dantey K; Schoedel K; Yergiyev O; Bartlett D; Rao UNM
Hum Pathol; 2017 Aug; 66():86-92. PubMed ID: 28300575
[TBL] [Abstract][Full Text] [Related]
12. A recurrent NTRK1 tyrosine kinase domain mutation pair is characteristic in a subset of dedifferentiated liposarcomas.
Lippai Z; Péterfia B; Papp G; Dezső K; Bedics G; Pápai Z; Lamers MH; Kuin RC; Szuhai K; Sápi Z
Eur J Cancer; 2024 May; 202():114005. PubMed ID: 38531265
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of the MDM2/HMGA2 ratio and histological tumor grade in dedifferentiated liposarcoma.
Yamashita K; Kohashi K; Yamada Y; Akatsuka S; Ikuta K; Nishida Y; Toyokuni S; Oda Y
Genes Chromosomes Cancer; 2021 Jan; 60(1):26-37. PubMed ID: 33111425
[TBL] [Abstract][Full Text] [Related]
14. The utility of fluorescence in situ hybridization (FISH) in determining DNA damage-inducible transcript 3 (DDIT3) amplification in dedifferentiated liposarcomas - an important diagnostic pitfall.
Kuczkiewicz-Siemion O; Wiśniewski P; Dansonka-Mieszkowska A; Grabowska-Kierył M; Olszewska K; Goryń T; Prochorec-Sobieszek M; Rutkowski P; Szumera-Ciećkiewicz A
Pathol Res Pract; 2021 Sep; 225():153555. PubMed ID: 34325315
[TBL] [Abstract][Full Text] [Related]
15. Expression of the preadipocyte marker ZFP423 is dysregulated between well-differentiated and dedifferentiated liposarcoma.
Dang TN; Tiongco RP; Brown LM; Taylor JL; Lyons JM; Lau FH; Floyd ZE
BMC Cancer; 2022 Mar; 22(1):300. PubMed ID: 35313831
[TBL] [Abstract][Full Text] [Related]
16. Dedifferentiated liposarcoma and pleomorphic liposarcoma: a comparative study of cytomorphology and MDM2/CDK4 expression on fine-needle aspiration.
Mariño-Enríquez A; Hornick JL; Dal Cin P; Cibas ES; Qian X
Cancer Cytopathol; 2014 Feb; 122(2):128-37. PubMed ID: 24227706
[TBL] [Abstract][Full Text] [Related]
17. MDM2 and CDK4 immunostainings are useful adjuncts in diagnosing well-differentiated and dedifferentiated liposarcoma subtypes: a comparative analysis of 559 soft tissue neoplasms with genetic data.
Binh MB; Sastre-Garau X; Guillou L; de Pinieux G; Terrier P; Lagacé R; Aurias A; Hostein I; Coindre JM
Am J Surg Pathol; 2005 Oct; 29(10):1340-7. PubMed ID: 16160477
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of Replication-Dependent Histone Signifies a Subset of Dedifferentiated Liposarcoma with Increased Aggressiveness.
Yoo Y; Park SY; Jo EB; Choi M; Lee KW; Hong D; Lee S; Lee CR; Lee Y; Um JY; Park JB; Seo SW; Choi YL; Kim S; Lee SG; Choi M
Cancers (Basel); 2021 Jun; 13(13):. PubMed ID: 34206586
[TBL] [Abstract][Full Text] [Related]
19. Increased H3K9me3 drives dedifferentiated phenotype via KLF6 repression in liposarcoma.
Keung EZ; Akdemir KC; Al Sannaa GA; Garnett J; Lev D; Torres KE; Lazar AJ; Rai K; Chin L
J Clin Invest; 2015 Aug; 125(8):2965-78. PubMed ID: 26193637
[TBL] [Abstract][Full Text] [Related]
20. Degree of
Bill KLJ; Seligson ND; Hays JL; Awasthi A; Demoret B; Stets CW; Duggan MC; Bupathi M; Brock GN; Millis SZ; Shakya R; Timmers CD; Wakely PE; Pollock RE; Chen JL
Oncologist; 2019 Jul; 24(7):989-996. PubMed ID: 31019022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
